中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
The Clinical Research and Latest Application of Genomic Assays in Early-Stage Breast Cancer

文献类型:期刊论文

作者Chen, Keyu1,2; Wu, Jiayi1,2; Fang, Ziru1,2; Shao, Xiying2; Wang, Xiaojia2
刊名TECHNOLOGY IN CANCER RESEARCH & TREATMENT
出版日期2022-09-01
卷号21
关键词early-stage breast cancer genomic expression profiles Oncotype DX MammaPrint RecurIndex prediction tools
ISSN号1533-0346
DOI10.1177/15330338221117402
通讯作者Wang, Xiaojia(wxiaojia0803@163.com)
英文摘要Breast cancer is a kind of malignant tumor that seriously endangers women's life and health. Once diagnosed, most patients will receive a combination of treatments to achieve a cure. However, breast cancer is a heterogeneous disease. Even with the same clinical stage and pathological features, its response to treatment and postoperative recurrence risk may still be completely different. With the advent of genomic assay, some patients with early-stage breast cancer who originally needed treatment can still achieve long-term disease-free survival without adjuvant chemotherapy, so as to achieve personalized and accurate treatment mode to a certain extent. In this paper, we reviewed the 5 most widely used and studied genomic panel technologies in breast cancer, namely Oncotype DX, MammaPrint, RecurIndex, PAM50, and EndoPredict, according to accessibility and availability. Based on the results of the completed or ongoing clinical studies, we summarized the origin, applicable population, and clinical efficacy of each detection method, and discussed the potential development prospect of detection technology in the future.
WOS关键词21-GENE RECURRENCE SCORE ; LATE DISTANT RECURRENCE ; CARCINOMA IN-SITU ; PAM50 RISK ; GENE-EXPRESSION ; LOCOREGIONAL RECURRENCE ; POSTMENOPAUSAL WOMEN ; INTRINSIC SUBTYPES ; ENDOCRINE THERAPY ; NEOADJUVANT CHEMOTHERAPY
资助项目National Key research and development program/International cooperation in science and technology innovation[2019YFE0196500] ; Key research and development projects in Zhejiang Province/International cooperation technology research and development and demonstration promotion projects[2020C04012]
WOS研究方向Oncology
语种英语
WOS记录号WOS:000856112700001
出版者SAGE PUBLICATIONS INC
资助机构National Key research and development program/International cooperation in science and technology innovation ; Key research and development projects in Zhejiang Province/International cooperation technology research and development and demonstration promotion projects
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/128980]  
专题中国科学院合肥物质科学研究院
通讯作者Wang, Xiaojia
作者单位1.Zhejiang Chinese Med Univ, Hangzhou, Zhejiang, Peoples R China
2.Chinese Acad Sci, Univ Chinese Acad Sci, Inst Basic Med & Canc IBMC, Canc Hosp,Zhejiang Canc Hosp, Hangzhou 310022, Zhejiang, Peoples R China
推荐引用方式
GB/T 7714
Chen, Keyu,Wu, Jiayi,Fang, Ziru,et al. The Clinical Research and Latest Application of Genomic Assays in Early-Stage Breast Cancer[J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT,2022,21.
APA Chen, Keyu,Wu, Jiayi,Fang, Ziru,Shao, Xiying,&Wang, Xiaojia.(2022).The Clinical Research and Latest Application of Genomic Assays in Early-Stage Breast Cancer.TECHNOLOGY IN CANCER RESEARCH & TREATMENT,21.
MLA Chen, Keyu,et al."The Clinical Research and Latest Application of Genomic Assays in Early-Stage Breast Cancer".TECHNOLOGY IN CANCER RESEARCH & TREATMENT 21(2022).

入库方式: OAI收割

来源:合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。